Center for Cancer Research: Clinical Trial Researching Combination Drug Therapy for Genitourinary Tumors
October 05, 2024
October 05, 2024
BETHESDA, Maryland, Oct. 5 (TNSres) -- The National Institutes of Health's Center for Cancer Research issued the following news:
Rare tumors of the genitourinary tract can appear in the kidney, bladder, ureters and penis. Two drugs -- sacituzumab govitecan and atezolizumab -- are each approved to treat other cancers. A clinical trial led by Andrea B. Apolo, M.D., Senior Investigator in the Genitourinary Malignancies Branch, is researching if the two drugs used together can help peop . . .
Rare tumors of the genitourinary tract can appear in the kidney, bladder, ureters and penis. Two drugs -- sacituzumab govitecan and atezolizumab -- are each approved to treat other cancers. A clinical trial led by Andrea B. Apolo, M.D., Senior Investigator in the Genitourinary Malignancies Branch, is researching if the two drugs used together can help peop . . .